159 related articles for article (PubMed ID: 37161573)
1. Towards the international interoperability of clinical research networks for rare diseases: recommendations from the IRDiRC Task Force.
Nabbout R; Zanello G; Baker D; Black L; Brambilla I; Buske OJ; Conklin LS; Davies EH; Julkowska D; Kim Y; Klopstock T; Nakamura H; Nielsen KG; Pariser AR; Pastor JC; Scarpa M; Smith M; Taruscio D; Groft S
Orphanet J Rare Dis; 2023 May; 18(1):109. PubMed ID: 37161573
[TBL] [Abstract][Full Text] [Related]
2. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
3. A Global Approach to Rare Diseases Research and Orphan Products Development: The International Rare Diseases Research Consortium (IRDiRC).
Cutillo CM; Austin CP; Groft SC
Adv Exp Med Biol; 2017; 1031():349-369. PubMed ID: 29214582
[TBL] [Abstract][Full Text] [Related]
4. Recommendations for the design of small population clinical trials.
Day S; Jonker AH; Lau LPL; Hilgers RD; Irony I; Larsson K; Roes KC; Stallard N
Orphanet J Rare Dis; 2018 Nov; 13(1):195. PubMed ID: 30400970
[TBL] [Abstract][Full Text] [Related]
5. The IRDiRC Chrysalis Task Force: making rare disease research attractive to companies.
Beaverson KL; Julkowska D; Letinturier MCV; Aartsma-Rus A; Austin J; Bueren J; Frost S; Hamamura M; Larkindale J; LaRosa G; Magenheim R; Merico A; Pasmooij AMG; Pirard V; Ekow Thomford N; Wada M; Wong-Rieger D; Hartman AL
Ther Adv Rare Dis; 2023; 4():26330040231188979. PubMed ID: 37529076
[TBL] [Abstract][Full Text] [Related]
6. The importance of international collaboration for rare diseases research: a European perspective.
Julkowska D; Austin CP; Cutillo CM; Gancberg D; Hager C; Halftermeyer J; Jonker AH; Lau LPL; Norstedt I; Rath A; Schuster R; Simelyte E; van Weely S
Gene Ther; 2017 Sep; 24(9):562-571. PubMed ID: 28440796
[TBL] [Abstract][Full Text] [Related]
7. 'IRDiRC Recognized Resources': a new mechanism to support scientists to conduct efficient, high-quality research for rare diseases.
Lochmüller H; Le Cam Y; Jonker AH; Lau LP; Baynam G; Kaufmann P; Lasko P; Dawkins HJ; Austin CP; Boycott KM
Eur J Hum Genet; 2017 Feb; 25(2):162-165. PubMed ID: 27782107
[TBL] [Abstract][Full Text] [Related]
8. The use or generation of biomedical data and existing medicines to discover and establish new treatments for patients with rare diseases - recommendations of the IRDiRC Data Mining and Repurposing Task Force.
Southall NT; Natarajan M; Lau LPL; Jonker AH; Deprez B; Guilliams T; Hunter L; Rademaker CM; Hivert V; Ardigò D;
Orphanet J Rare Dis; 2019 Oct; 14(1):225. PubMed ID: 31615551
[TBL] [Abstract][Full Text] [Related]
9. Rare Diseases: Joining Mainstream Research and Treatment Based on Reliable Epidemiological Data.
Groft SC; Posada de la Paz M
Adv Exp Med Biol; 2017; 1031():3-21. PubMed ID: 29214563
[TBL] [Abstract][Full Text] [Related]
10. Critical Care Network in the State of Qatar.
Hijjeh M; Al Shaikh L; Alinier G; Selwood D; Malmstrom F; Hassan IF
Qatar Med J; 2019; 2019(2):2. PubMed ID: 31763205
[TBL] [Abstract][Full Text] [Related]
11. A research roadmap for complementary and alternative medicine - what we need to know by 2020.
Fischer F; Lewith G; Witt CM; Linde K; von Ammon K; Cardini F; Falkenberg T; Fønnebø V; Johannessen H; Reiter B; Uehleke B; Weidenhammer W; Brinkhaus B
Forsch Komplementmed; 2014; 21(2):e1-16. PubMed ID: 24851850
[TBL] [Abstract][Full Text] [Related]
12. The International Rare Diseases Research Consortium: Policies and Guidelines to maximize impact.
Lochmüller H; Torrent I Farnell J; Le Cam Y; Jonker AH; Lau LP; Baynam G; Kaufmann P; Dawkins HJ; Lasko P; Austin CP; Boycott KM;
Eur J Hum Genet; 2017 Dec; 25(12):1293-1302. PubMed ID: 29158551
[TBL] [Abstract][Full Text] [Related]
13. NIH Roundtable on Opportunities to Advance Research on Neurologic and Psychiatric Emergencies.
D'Onofrio G; Jauch E; Jagoda A; Allen MH; Anglin D; Barsan WG; Berger RP; Bobrow BJ; Boudreaux ED; Bushnell C; Chan YF; Currier G; Eggly S; Ichord R; Larkin GL; Laskowitz D; Neumar RW; Newman-Toker DE; Quinn J; Shear K; Todd KH; Zatzick D;
Ann Emerg Med; 2010 Nov; 56(5):551-64. PubMed ID: 21036295
[TBL] [Abstract][Full Text] [Related]
14. Global health for rare diseases through primary care.
Baynam G; Hartman AL; Letinturier MCV; Bolz-Johnson M; Carrion P; Grady AC; Dong X; Dooms M; Dreyer L; Graessner H; Granados A; Groza T; Houwink E; Jamuar SS; Vasquez-Loarte T; Tumiene B; Wiafe SA; Bjornson-Pennell H; Groft S
Lancet Glob Health; 2024 Jul; 12(7):e1192-e1199. PubMed ID: 38876765
[TBL] [Abstract][Full Text] [Related]
15. Implementing efficient and sustainable collaboration between National Immunization Technical Advisory Groups: Report on the 3rd International Technical Meeting, Paris, France, 8-9 December 2014.
Perronne C; Adjagba A; Duclos P; Floret D; Houweling H; Le Goaster C; Lévy-Brühl D; Meyer F; Senouci K; Wichmann O
Vaccine; 2016 Mar; 34(11):1325-30. PubMed ID: 26859237
[TBL] [Abstract][Full Text] [Related]
16. Progress in Rare Diseases Research 2010-2016: An IRDiRC Perspective.
Dawkins HJS; Draghia-Akli R; Lasko P; Lau LPL; Jonker AH; Cutillo CM; Rath A; Boycott KM; Baynam G; Lochmüller H; Kaufmann P; Le Cam Y; Hivert V; Austin CP;
Clin Transl Sci; 2018 Jan; 11(1):11-20. PubMed ID: 28796411
[No Abstract] [Full Text] [Related]
17. The pooling of manpower and resources through the establishment of European reference networks and rare disease patient registries is a necessary area of collaboration for rare renal disorders.
Parker S
Nephrol Dial Transplant; 2014 Sep; 29 Suppl 4():iv9-14. PubMed ID: 25165190
[TBL] [Abstract][Full Text] [Related]
18. RD-Connect: an integrated platform connecting databases, registries, biobanks and clinical bioinformatics for rare disease research.
Thompson R; Johnston L; Taruscio D; Monaco L; Béroud C; Gut IG; Hansson MG; 't Hoen PB; Patrinos GP; Dawkins H; Ensini M; Zatloukal K; Koubi D; Heslop E; Paschall JE; Posada M; Robinson PN; Bushby K; Lochmüller H
J Gen Intern Med; 2014 Aug; 29 Suppl 3(Suppl 3):S780-7. PubMed ID: 25029978
[TBL] [Abstract][Full Text] [Related]
19. Model consent clauses for rare disease research.
Nguyen MT; Goldblatt J; Isasi R; Jagut M; Jonker AH; Kaufmann P; Ouillade L; Molnar-Gabor F; Shabani M; Sid E; Tassé AM; Wong-Rieger D; Knoppers BM;
BMC Med Ethics; 2019 Aug; 20(1):55. PubMed ID: 31370847
[TBL] [Abstract][Full Text] [Related]
20. Share and protect our health data: an evidence based approach to rare disease patients' perspectives on data sharing and data protection - quantitative survey and recommendations.
Courbier S; Dimond R; Bros-Facer V
Orphanet J Rare Dis; 2019 Jul; 14(1):175. PubMed ID: 31300010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
